The research

The astaxanthin
research library

The human trials, organised by body system.
Every study linked straight to PubMed.
Read the evidence, and its limits, yourself.
Reviewed by  Dr Ron Goedeke     ·    Every study on PubMed    ·    Last checked June 2026
Every study behind this site, grouped by body system and linked straight to PubMed, so nothing has to be taken on trust. The evidence isn’t equally strong everywhere and the tags say so: heart and skin rest on meta-analyses, eyes are modest, exercise is mixed, joints and brain are thin. It’s a curated selection of the strongest human research, not the whole literature; it flags combination products and specific patient groups, and leaves out the animal-only and marketing padding common to astaxanthin reading lists (joints excepted, and clearly marked).

Jump to

01

How it works

02

Skin

03

Eyes

04

Heart

05

Joints

06

Brain

07

Exercise

08

Reproductive health

09

Immune

10

Absorption

11

Safety

12

Animal (dogs)

01 ·

 3 studies

How astaxanthin works

The mechanism and overview reviews that underpin everything else.

Fakhri (2018)

REVIEW
Reviews astaxanthin’s antioxidant and anti-inflammatory mechanisms and its documented biological activities across body systems.

Donoso (2021)

Review
An evidence-based review focused specifically on astaxanthin’s human clinical trials; reports antioxidant capacity many times that of vitamin E.

Ambati (2014)

Review
Reviews astaxanthin’s natural sources, extraction and stability; Haematococcus algae holds up to 3.8% astaxanthin by dry weight.

02 ·

 5 studies

Skin

Among the strongest and most consistent human evidence, now including meta-analysis.

Zhou (2021)

Meta-analysis
Pooled nine randomised skin trials: oral astaxanthin significantly improved skin moisture and elasticity, but did not significantly reduce wrinkle depth.

Tominaga (2012)

RCT
At 6 mg a day, improved skin wrinkles, elasticity, age spots and moisture in both women and men.

Ito (2018)

RCT
At 4 mg a day, improved the skin’s resistance to UV (raised the minimal erythema dose) and reduced UV-induced moisture loss in healthy adults.

Davinelli (2018)

Review
Comprehensive review of astaxanthin’s photoprotective, antioxidant and anti-inflammatory effects in skin.

Ng (2020)

Systematic review
Reviewed eleven skin trials: improvements in texture, wrinkles and moisture, with no serious adverse events reported.

03 ·

 5 studies

Eyes

Real but modest benefits, mostly around eye strain, focusing and ocular blood flow.

Saito (2012)

Clinical trial
At 12 mg a day, improved choroidal (retinal) blood flow.

Hashimoto (2013)

Clinical study
At 6 mg a day, raised antioxidant activity and lowered oxidative markers in the eye’s aqueous humour.

Kizawa (2021)

RCT
A combination of astaxanthin, anthocyanin and lutein improved focusing (accommodation) in adults with screen-related eye fatigue. A combination product, so astaxanthin’s individual role isn’t isolated.

Hecht (2025)

RCT
At 4 mg a day, reduced digital eye strain and visual fatigue in school-aged children.

Martinez-Perez (2025)

Systematic review
Carotenoids including astaxanthin gave modest benefits for visual fatigue, but no consistent effect on myopia progression.

04 ·

 9 studies

Heart and cardiovascular

The best-evidenced area. Astaxanthin reliably raises HDL, lowers triglycerides, and reduces inflammation and LDL oxidation. Its effect on LDL levels is genuinely mixed: several meta-analyses find none, but longer trials in higher-risk groups such as prediabetes and coronary disease show real LDL and total-cholesterol reductions. Both sides are shown below.

Yoshida (2010)

RCT
Raised HDL cholesterol and adiponectin and lowered triglycerides in people with mildly high triglycerides.

Choi (2011)

RCT
Lowered LDL, ApoB and oxidative-stress markers in overweight adults.

Mashhadi (2018)

RCT
Lowered triglycerides and systolic blood pressure in people with type 2 diabetes.

Ciaraldi (2023)

RCT
In adults with prediabetes and dyslipidaemia, 12 mg a day for 24 weeks significantly lowered LDL and total cholesterol and reduced several cardiovascular-risk markers (fibrinogen, L-selectin, fetuin-A). NIH-funded, and one of the longer trials.

Heidari (2023)

RCT
In people with coronary artery disease, 12 mg a day for 8 weeks significantly lowered total cholesterol and LDL, with no change in triglycerides or HDL.

Xia (2020)

Meta-analysis
Pooled 14 randomised trials: astaxanthin reliably raised HDL, and lowered CRP at higher doses, but did not change LDL or blood pressure overall.

Leung (2022)

Meta-analysis
In adults at risk of metabolic syndrome, pooled trials found a significant LDL-lowering effect, plus marginal reductions in total cholesterol and systolic blood pressure.

Fornari Laurindo (2025)

Meta-analysis
Higher-dose analysis: raised HDL and lowered triglycerides, with no significant change in LDL or total cholesterol.

Mohammadi (2025)

RCT
In 80 people with chronic heart failure, 20 mg a day for 8 weeks improved antioxidant capacity, lowered oxidative-stress markers and serum uric acid, and improved dyspnea and fatigue versus placebo.

05 ·

 7 studies

Joints

Still the thinnest human evidence of any area here, but no longer empty: two human trials now exist, one in rheumatoid arthritis using astaxanthin alone and one in osteoarthritis using a combination product. Both are recent and modest. The mechanism is well supported in animal and laboratory models, several of which are included below and clearly marked as preclinical.

Grigorian (2025)

RCT
In 60 people with rheumatoid arthritis, 20 mg a day of astaxanthin alone for 8 weeks significantly improved disease activity (DAS-28), physical function (HAQ) and ESR versus placebo. The effect on pain was only marginal and IL-6 didn’t change. This is the only trial to test astaxanthin on its own for a joint condition.

Hill (2023)

RCT
A combination of krill oil, astaxanthin and hyaluronic acid reduced joint pain in people with mild knee or hip osteoarthritis. Manufacturer-funded, and unlike the trial above, astaxanthin’s individual contribution can’t be isolated.

Sun (2019)

Animal study
In a mouse osteoarthritis model and in cartilage cells, astaxanthin protected cartilage and reduced inflammation and breakdown by activating the Nrf2 antioxidant pathway. Preclinical only.

Qin (2024)

Animal study

In a mouse osteoarthritis model and in cartilage cells, astaxanthin reduced inflammation and protected cartilage by upregulating SIRT1. Preclinical only.

Wang (2022)

Animal study

In rat cartilage cells and a rat osteoarthritis model, astaxanthin slowed cartilage breakdown by inhibiting ferroptosis (iron-driven cell death) and protecting mitochondrial function. Preclinical only.

Huang (2015)

Animal study

In a rabbit osteoarthritis model, astaxanthin reduced cartilage degradation and suppressed the cartilage-degrading enzymes (MMP-1, -3 and -13) that drive joint damage. Preclinical only.

Kumar (2019)

Animal study

In a rat model of rheumatoid-type (adjuvant-induced) arthritis, oral astaxanthin reduced paw swelling, improved arthritis scores and lowered inflammatory and oxidative markers. Preclinical only.

06 ·

 5 studies

Brain and cognition

A compelling mechanism, but early and statistically weak human data.

Katagiri (2012)

RCT
Cognitive scores improved in older adults with age-related forgetfulness, though the trial was too small to reach statistical significance versus placebo.

Ito (2018)

RCT
Astaxanthin combined with sesamin improved processing and psychomotor speed in people with mild cognitive impairment. A small manufacturer-run pilot.

Liu (2024)

Meta-analysis
Pooled eleven trials: the effect on cognition was only marginally significant for accuracy and not significant for reaction time.

Utomo (2024)

Systematic review
Reviewed the cognitive trials: improvements were reported by most participants but weren’t statistically robust.

Grimmig (2017)

Review
Reviews astaxanthin’s neuroprotective mechanisms, including its ability to cross into the brain and calm neuroinflammation.

07 ·

 4 studies

Exercise and physical performance

Promising in theory and in animals, but the human evidence is genuinely mixed: some trials show clear benefits, others show little. Both are shown here.

Tsao (2025)

RCT
In physically active young men, 28 mg a day significantly increased time to exhaustion on a cycling test and reduced markers of muscle damage and oxidative stress. Small (10 participants) and short-term.

Liu (2021)

RCT
In healthy older adults, astaxanthin combined with aerobic training improved muscle endurance and fat oxidation more than training alone.

Wika (2023)

RCT
In overweight adults, 12 mg a day for 4 weeks lowered heart rate and carbohydrate oxidation during exercise, though it did not change fat oxidation.

Brown (2018)

Review
Reviews astaxanthin in exercise: the animal data are promising, but human results for performance and recovery remain mixed and inconsistent.

08 ·

 4 studies

Women's reproductive health

A fast-growing area of recent trials, almost all in specific conditions such as PCOS and infertility, and focused on inflammation, oxidative stress and fertility-treatment outcomes. This is not evidence for boosting fertility in the general population.

Maleki-Hajiagha (2024)

Meta-analysis
Pooled clinical trials: astaxanthin improved oocyte maturation and antioxidant capacity in the follicular fluid of women undergoing fertility treatment; broader pregnancy outcomes were not significantly changed.

Rostami (2023)

RCT
In women with endometriosis undergoing assisted reproduction, 6 mg a day lowered inflammation and oxidative stress and improved egg and embryo measures.

Shafie (2024)

RCT
In women with poor ovarian response, 12 mg a day lowered inflammation and oxidative stress and improved some fertility-treatment outcomes.

Jabarpour (2023)

RCT
In women with PCOS, astaxanthin improved insulin resistance, lipid profile, blood pressure and oxidative stress.

09 ·

 1 studies

Immune function

Human evidence for immune and anti-inflammatory effects.

Park (2010)

RCT
At 2 to 8 mg a day, lowered CRP and a DNA-damage marker and enhanced immune response (antibody levels, natural killer cell activity) in healthy young women.

10 ·

 1 studies

Absorption and dosage

Why astaxanthin is taken with fat, and how long it stays in the body.

Mercke Odeberg (2003)

Pharmacokinetic study
Lipid-based delivery raised astaxanthin’s bioavailability by up to nearly fourfold; its elimination half-life is around 16 hours.

11 ·

 1 studies

Safety

The definitive human safety assessment.

Brendler & Williamson (2019

Safety review
Reviewed 87 human studies of natural astaxanthin, 35 at 12 mg a day or more, and found no safety concerns. Also sets out why natural and synthetic astaxanthin shouldn’t share dose limits.

12 ·

 3 studies

Animal studies (dogs)

The canine evidence behind astaxanthin for pets.

Park (2010)

Animal study
Dogs and cats absorb astaxanthin from the diet, carrying it mainly on HDL and into immune cells, much as humans do.

Chew (2011)

Animal study
Enhanced immune response and lowered inflammation markers in dogs supplemented with astaxanthin.

Murai (2019)

Animal study
Improved antioxidant status and lipid metabolism in both healthy and obese dogs.
Dr Ron

Medically reviewed

Dr Ron Goedeke

Functional medicine physician based in Auckland, with 25 years of clinical experience in nutritional and anti-aging medicine. Founding member of the New Zealand College of Appearance Medicine. Member of the American Academy of Anti-Aging Medicine since 1999.
Last reviewed: JUNE 2026